The transition from viral to autoimmune myocarditis.
Myocarditis offers a unique opportunity to study the factors contributing to its transition from a viral infection to an autoimmune disease. In this article, we review recent studies on the role of nitric oxide (NO), gamma interferon (IFN-gamma) and interleukin 12 (IL-12) in the progression from early (viral) to late (autoimmune) phases of myocarditis induced by Coxsackievirus B3 (CB3) in highly susceptible (A.CA) and moderately susceptible (B10.M) mice. NO plays a paradoxical role, being protective in early stages but detrimental later in the course of disease. Treatment with antibody to IFN-gamma reduced early disease, but had little effect on the severity of cardiac lesions at later times. Treatment with recombinant (r) IL-12 significantly reduced the autoimmune cardiac lesions in moderately susceptible B10.M mice, but had no measurable effect in highly susceptible A.CA animals. These studies provide evidence that the profile of inflammatory mediators produced early in the course of viral infection determines the later development of autoimmune disease.
Hill
S L
SL
W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Medical Institutions, JHU School of Hygiene and Public Health, Baltimore, MD 21205, USA.
Rose
N R
NR
D000818:Animals; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology* / Q000378:metabolism; D002311:Cardiomyopathy, Dilated / Q000378:metabolism; D004195:Disease Models, Animal; D029822:Enterovirus B, Human / Q000378:metabolism; D004769:Enterovirus Infections / Q000150:complications / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D018664:Interleukin-12 / Q000378:metabolism; D051379:Mice; D009205:Myocarditis / Q000209:etiology / Q000276:immunology* / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism*
D018664:Interleukin-12; D009569:Nitric Oxide; D007371:Interferon-gamma